Portal de Periódicos da CAPES

Thyroid eye disease: Redefining its management—A review

2021; Wiley; Volume: 49; Issue: 2 Linguagem: Inglês

10.1111/ceo.13899

1442-9071

Amy Patel Jain, Pimkwan Jaru-ampornpan, Raymond S. Douglas,

Glaucoma and retinal disorders

Abstract Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatment plan to reverse the disease endpoints. Teprotumumab offers an early, safe therapeutic intervention to help reverse disease end points such as diplopia and proptosis and improve quality of life.